People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Biotech / Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aion Therapeutic Inc. | — | Biotech / Pharma | Series A | $5.8M | $38.9M | 2023 |
| Contract Capital Inc. | — | Other | Pre-Seed | $150K | $3.5M | 2015 |
Paul Crath at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Crath on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rakesh Malhotra | 1 | 4 |
| Larry Horwitz | 1 | 1 |
| Graham Simmonds | 1 | 1 |
| Anthony, Dr. Hall | 1 | 1 |
| Sara Lee Irwin | 1 | 1 |
| Alan Surtees | 1 | 1 |
| Christopher Kerr | 1 | 1 |
| Bernie Shimkovitz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.